CHANGES OF ANTIGEN EXPRESSION ON HUMAN HEPATOMA-CELL LINES CAUSED BY SODIUM-BUTYRATE, A DIFFERENTIATION INDUCER

被引:20
作者
SAITO, H
TADA, S
EBINUMA, H
TSUNEMATSU, S
KAGAWA, T
KUMAGAI, N
INAGAKI, Y
WATANABE, T
TSUCHIMOTO, K
MORIZANE, T
ISHII, H
TSUCHIYA, M
机构
[1] Department of Internal Medicine, School of Medicine, Keio University, Tokyo, 160, 35 Shinanomachi, Shinjukuku
[2] Department of Internal Medicine, Kitasato Institute Hospital, Tokyo, 108
[3] Department of Internal Medicine, Nihon Kohkan Hospital, Kawasaki, 108, 1-2-1 Kohkandori, Kawasaki-ku
[4] Department of Internal Medicine, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, 170, 2-8-1 Minamiohtsuka, Toshima-ku
[5] Department of Internal Medicine, Kanagawa Dental College, Kanagawa, 238, 82 Inaokacho, Yokosuka
关键词
HEPATOCELLULAR CARCINOMA; DIFFERENTIATION; SODIUM BUTYRATE; MONOCLONAL ANTIBODY; LIVER-SPECIFIC ANTIGEN;
D O I
10.1007/BF02349279
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We have previously reported the effect of a differentiation inducer, sodium butyrate (SB), on human hepatocellular carcinoma (HCC) cell lines, demonstrating that it was a potent inducer of differentiation. In the present study, we investigated the alteration in expression of an antigen defined by a murine monoclonal antibody, H2, as well as alterations in the expression of other antigens, on the HCC cell lines HCC-T, HCC-M, and PLC/PRF/5, since it is known that specific antigenic changes occur during the differentiation of leukemic cells. The expression of the antigen defined by H2 increased immunocytochemically on HCC-T, HCC-M, and PLC/PRF/5 during treatment with SB. A flowcytometric study showed that almost all the HCC-T and HCC-M cells treated with SB highly expressed this antigen after 5 days' treatment. The antigen expression detected by H2 decreased after the removal of SB from the medium. On the other hand, antigen expression detected by another monoclonal antibody, 5C11, was not changed by this treatment. The expression of intracellular adhesion molecule (ICAM)-1 in HCC-T increased slightly, but that of beta2-microglobulin and HLA-DR did not change. These results demonstrated that some antigen expression was changed by SB treatment and that the antigen defined by H2 seemed to be highly expressed on human HCC cells in the differentiated state.
引用
收藏
页码:733 / 739
页数:7
相关论文
共 25 条
[1]  
Mullins T.D., Kern H.F., Metzgar R.S., Ultrastructural differentiation of sodium butyrate-treated human pancreatic adenocarcinoma cell lines, Pancreas, 6, pp. 578-587, (1992)
[2]  
Hara A., Hibi T., Yoshioka M., Et al., Changes of proliferative activity and phenotypes in spontaneous differentiation of a colon cancer cell line, Jpn J Cancer Res, 84, pp. 625-632, (1993)
[3]  
Saito H., Morizane T., Watanabe T., Et al., Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC-M, and HCC-T, Int J Cancer, 48, pp. 291-296, (1991)
[4]  
Saito H., Morizane T., Watanabe T., Et al., Study of oncogene expression and its changes induced by sodium butyrate in human hepatoma cell lines, Gastroenterology, 98, (1990)
[5]  
Nojiri H., Takaku F., Saito M., Characteristic expression of glycosphingolipid profiles in the bipotential cell differentiation of human promyelocytic leukemia cell line HL-60, Blood, 64, pp. 534-541, (1984)
[6]  
Momoi T., Yokota J., Alterations of glycolipids of human leukemia cell line HL-60 during differentiation, J Natl Cancer Inst, 70, pp. 229-236, (1983)
[7]  
Nakao K., Nakata K., Mitsuoka S., Et al., Transforming growth factor β, differentially regulates α-fetoprotein and albumin in HuH-7 human hepatoma cells, Biochem Biophys Res Commun, 174, pp. 1294-1299, (1991)
[8]  
Fukutomi Y., Omori M., Muto Y., Et al., Inhibitory effects of acyclic retinoid (polyprenoic acid) and its hydroxy derivative on cell growth and on secretion of α-fetoprotein in human hepatoma-derived cell line (PLC/PRF/5), Jpn J Cancer Res, 81, pp. 1281-1285, (1990)
[9]  
Saito H., Kagawa T., Tada S., Et al., Effect of dexamethasone, dimethylsulfoxide, and sodium butyrate on a human hepatoma cell line PLC/PRF/5, Cancer Biochem Biophys, 13, pp. 75-84, (1992)
[10]  
Saito H., Morizane T., Iino A., Et al., Characterization of human liver-specific antigen 1 (HLSA1) defined by the murine monoclonal antibody H2, Nippon Shokakibyo Gakkai Zasshi, 84, pp. 675-683, (1987)